Skip to content

Clinical trials

Mood Disorders trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mood Disorders Country / region: Russia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20112
20121
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.3
Takeda2
H. Lundbeck A/S1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
National Institute of Mental Health (NIMH)1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mood Disorders9
Major Depressive Disorder7
Depressive Disorder6
Mental Disorders5
Affective Disorders, Psychotic1
Anxiety Disorders1
Bipolar Disorder1
Craniocerebral Trauma1
Dysthymic Disorder1
Mania1

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.